“It’s time you started blogging, too.” Serge Bernasconi, CEO of MedTech Europe, EDMA and Eucomed, heard those words for the first time a few days ago, and, lo and behold, his first blog post is now up. It’s chatty and informal, as it should be, but also offers some perspectives on what the associations have accomplished in 2012 and sheds light on their objectives in 2013.
Regular readers of medtechinsider will recall that the MedTech Europe alliance was launched at October’s MedTech Forum in Brussels (“MedTech Forum 2012 and Winning Europe in 2020“). The alliance “represents a great opportunity to serve the common interests of the in vitro diagnostics and medical device industries better and more efficiently,” writes Bernasconi. In particular, MedTech Europe will use its considerable influence to further demonstrate the virtue of value-based innovation, which improves health outcomes in a cost-effective manner. But what will keep it—and all medtech stakeholders, for that matter—very busy in the months ahead are the new medical device and IVD regulations, notes Bernasconi. On that note, “keep an eye out this week for Eucomed’s official response to the European Commission’s proposal for a revised MDD,” he writes. It will break down the important issues and explain how Europe’s world-class system can be made even better for patients and medical progress, adds Bernasconi.